Personalized cancer medicine: next steps in the genomic era

G. Ciriello, M.L. Miller, B.A. Aksoy et al., Emerging landscape of oncogenic signatures across human cancers. Nat Genet 45, 1127–1133 (2013) International Cancer Genome Consortium, T.J. Hudson, W. Anderson et al., International network of cancer genome projects. Nature 464, 993–998 (2010) A. Geurts van Kessel, The cancer genome: from structure to function. Cell Oncol 37, 155–165 (2014) C. Santos, C. Sanz-Pamplona, E. Nadal, et al., Intrinsic cancer subtypes. Next steps into personalized medicine. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0203-7 M. Vitiello, L. Poliseno, Long non coding RNAs in cancer: implications for personalised therapy. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0180-x A. Geurts van Kessel, New insights and clinical advancements in cellular oncology. Cell Oncol 35, 139–147 (2012) L. Van Neste, W. van Criekinge, We are all individuals… bioinformatics in the personalized medicine era. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0195-3 L. Prudkin, P. Nucifero, Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0192-6 L.H. Mammatas, H.M. Verheul, N.H. Hendrikse, et al., Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0194-4 L. Pesenti, M. Gusella, S.M. Sirchia et al., Germline oncopharmacogenetics, a promising field in cancer therapy. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0214-4